CCG Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$689K Buy
574
+50
+10% +$51.1K 0.16% 77
2026
Q1
$482K Buy
524
+21
+4% +$21.3K 0.13% 89
2025
Q4
$541K Sell
503
-57
-10% -$54.5K 0.23% 58
2025
Q3
$427K Buy
560
+15
+3% +$11.2K 0.2% 52
2025
Q2
$425K Sell
545
-9
-2% -$6.99K 0.22% 51
2025
Q1
$458K Buy
554
+40
+8% +$33.3K 0.27% 45
2024
Q4
$397K Sell
514
-83
-14% -$68.7K 0.22% 51
2024
Q3
$529K Buy
597
+41
+7% +$36.9K 0.3% 43
2024
Q2
$503K Buy
556
+226
+68% +$181K 0.28% 42
2024
Q1
$257K Buy
+330
New +$235K 0.15% 59

Other funds holding LLY

CCG Wealth Management's LLY Position: Q2 2026 in Review

CCG Wealth Management increased its Eli Lilly (LLY) stake by 9.5% in Q2 2026, buying an estimated $51.1K and bringing the position to 574 shares worth $689K. The position accounts for 0.16% of the portfolio, ranked #77.

CCG Wealth Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • CCG Wealth Management held 574 shares of Eli Lilly worth $689K as of Q2 2026.
  • CCG Wealth Management bought 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.16% of CCG Wealth Management's portfolio in Q2 2026, its #77 holding.
  • CCG Wealth Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on CCG Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.